Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200061579Phase 4Completed
Phase 4, randomised trial in essential hypertension and perioperative hypotension comparing Ciprofol induction arm, Propofol induction arm and Etomidate induction arm (3 arms). Primary endpoint: Incidence of post-induction hypotension. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200061579.